PEREGRINE CAPITAL MANAGEMENT LLC
Position in AXSM — Axsome Therapeutics, Inc.
CIK 764529
MINNEAPOLIS, MN
Position in AXSM
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$7,993,969
-$523,082 QoQ
Shares Held
47,296
+1.4% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 36.9206698240866.ToString("F0")%
Shared 0.ToString("F0")%
None 63.0793301759134.ToString("F0")%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PEREGRINE CAPITAL MANAGEMENT LLC holds $94,824,642 across 14 Biotechnology names. AXSM ranks #3 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XENE |
Xenon Pharmaceuticals Inc.
|
143,136 | $8,323,358 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
146,923 | $8,299,680 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
This page
|
47,296 | $7,993,969 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
201,959 | $7,773,401 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
306,272 | $7,215,768 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
146,606 | $7,207,150 | |
| 7 | CYTK |
Cytokinetics Inc
|
103,626 | $6,829,989 | |
| 8 | EWTX |
Edgewise Therapeutics, Inc.
|
208,672 | $6,573,168 |
All Filings in AXSM
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,993,969 | 47,296 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $8,517,051 | 46,633 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $7,836,075 | 64,521 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $7,669,324 | 73,468 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $6,965,260 | 59,721 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $7,376,892 | 87,187 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $6,464,259 | 71,929 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $7,033,526 | 87,373 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $6,873,573 | 86,135 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $6,750,585 | 84,817 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $6,366,349 | 91,091 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $7,727,321 | 107,533 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $6,678,772 | 108,281 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $7,434,252 | 96,386 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $4,767,156 | 106,839 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $5,411,177 | 141,284 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $6,856,501 | 165,656 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $4,507,078 | 119,298 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $3,821,349 | 115,939 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $9,372,555 | 138,935 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $7,270,291 | 128,405 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $11,921,097 | 146,325 | Shares | Sole | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||